Ischemia time remains a significant limiting factor for successful extremity replantation and transplantation. Compared to the cold storage normothermic exsitu perfusion is a novel method of a limb preservation by maintaining physiologic cellular metabolism avoiding the deleterious effects of hypoxia and cooling. The purpose of our study was to establish the efficacy of normothermic ex-situ perfusion in preserving viability and function of human upper extremities.
RESULTS:
Perfused arms retained physiological parameters and function up to 48 hours with a final weight increase of 8.33%±0.07, mean muscle temperature of 35.5 ± 0.61 o C, and tissue oxygen saturation 90.44%±11.2. Average values of final myoglobin and CK concentrations were 31863.33 ± 18621.31ng/mL, and 68456.67 ± 32236.09U/L. Thermography and ICG angiography depicted uniform peripheral perfusion throughout the experiment. Electrical stimulation of median, ulnar and radial nerves displayed no muscle contraction at the beginning, however, muscle contraction recovered gradually and was preserved until the end of perfusion. In the control group, no contraction was identified throughout the experiments.
CONCLUSION:
Ex-situ normothermic limb perfusion shows potential in overcoming the present standard of care (cold preservation) improving ischemia time for large segments and envisioning a radical change in the management of traumatic amputations and upper extremity transplantation. 
BACKGROUND:
The "Wide Awake Local Anesthesia No Tourniquet" (WALANT) technique is being increasingly applied to hand surgery owing to its benefits of decreased patient discomfort, reduced cost, shorter hospital stay, improved patient safety, and the ability to perform active intraoperative examinations. The aim of our study is to analyze the cost savings and efficiency of performing A1 pulley release for treatment of trigger finger using the WALANT technique in a major city hospital procedure room as compared with the standard tourniquet, operating room approach.
METHODS:
Patients who underwent trigger finger release either in the main hospital operating room or procedure room between 2012-2017 were identified. Both paper and electronic medical records were reviewed and demographics collected including age, BMI, smoking status, medical comorbidities, and chief complaint with any prior conservative management noted. Additionally, procedural information was obtained including date of surgery, procedure site and length of operation, amount of local anesthesia used, turnover time, and cost of supplies. Patients were followed for an average of 82 days in the procedure room group and 242 days in the operating room group, with post-operative complications noted.
RESULTS:
Thirty-nine procedure room and 37 operating room patients undergoing A1 pulley release were identified from October 2012 to April 2017. Patients in the procedure room received solely local anesthesia, while patients in the operating room received local anesthesia, MAC, or general endotracheal or LMA intubation. In both the procedure room and operating room, each finger requiring release was treated with roughly 7.6 cc of local anesthetic.
Cases performed in the procedure room were of overall similar duration to those performed in the main operating room (21.4 ± 7 minutes vs. 23.5 ± 14.3 minutes, respectively; p = .942). However, procedure room cases had an overall shorter room turnover time compared to the main operating room (31.1 ± 11.1 minutes vs. 65.3 ± 17.7 minutes respectively; p < .001).
Additionally, costs of both OR time and instruments were significantly less in the procedure room as compared to the main OR. The cost of the instrument tray utilized for trigger finger release was calculated as $3,304.25 in the main OR and $993.79 in the procedure room. Cost per minute for all personal services in the operating room, including anesthesia and nursing services, was calculated to be $44/ minute, a cost that was virtually absent in the procedure room. Lastly, there was no difference in complication rates between the two groups.
CONCLUSION:
We conclude that performing A1 pulley release for treatment of trigger finger using the WALANT technique is both cost effective and time efficient compared to performing the same procedure in the main OR of a major city public hospital.
Cost Analysis of Trigger Finger Treatment
Presenter: Raysa Cabrejo, BA Co-Author: J. Grant Thomson, MD, MSc Affiliation: Yale, New Haven, CT PURPOSE: The aim of this study was to perform a costeffectiveness analysis of the most effective treatment of trigger utilizing hospital data, including actual hospital charges.
METHODS:
A total of 1750 encounters belonging to 1220 individual patients treated for trigger finger (ICD-9: 727.03) over a period of 3 years were studied. Utilizing CPT codes for the injection of the tendon sheath (20550) and tendon sheath incision (26055) it was determined whether a patient was treated with injection or surgery. Diabetes was determined from previous diagnosis of diabetes by ICD-9, a total of 20% of the sample (n=248). The probability of success of each treatment and the average cost of each treatment were enterered into a Markov model utilizing R software.
RESULTS:
The overall success of the first steroid injection for trigger finger treatment was 63%, the second injection was 67%. Surgery was 100% effective. The average cost of a steroid injection was $506 and the average cost of trigger finger surgery was $5307. The recurrence rates were similar in patients with diabetes, success of treatment of first steroid injection was 63%, the second was 64% and the cost of surgery was $5380.
CONCLUSION:
Markov model demonstrates that the most cost-effective course of treatment for this data set is two steroid injections followed by surgery. Further analysis of the factors affecting surgical success and costs along with their effects on the Markov model analysis will be presented.
